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Background
Stroke is a serious and common disorder and a major cause of death worldwide. The 
pathogenesis of stroke is multifactorial and not fully understood. Although several trig-
gering factors have been already identified, they do no account for all the cases of stroke 
and new risk factors have been proposed (Díaz and Sempere 2004). Among them, sleep 
apnea/hypopnea syndrome (SAHS) is now recognized as an important and independ-
ent risk factor for cardiovascular disease and stroke, as demonstrated in cross-sectional 
(Yaggi et  al. 2005) and longitudinal (Arzt et  al. 2005) studies. Intermittent hypoxia, 
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mean cerebral blood flow velocity (MFV) (52 ± 9 vs 60 ± 12 cms/s, p < 0.001) and BHT 
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intrathoracic pressure swings and sympathetic activation, all as a result from recurrent 
upper airway obstruction, could promote atherogenesis via intermediate mechanisms 
such as oxidative stress (Lavie 2003), endothelial dysfunction (Ip et al. 2004) or increased 
procoagulant activity (Chin et al. 1996).
Several specific pathogenic mechanisms could explain the high incidence of stroke in 
SAHS. Obstructive—but not central—apneas have been shown to cause irregularity in 
cerebral blood flow velocity (Netzer et al. 1998) and could precipitate nocturnal cerebral 
ischemia in high-risk patients (Dyken et al. 2004). Moreover, early signs of great-vessel 
atherosclerosis (Baguet et al. 2005), but also higher incidence of silent brain infarctions 
(Minoguchi et  al. 2007) has been detected in patients with SAHS. These latter results 
suggest a possible involvement of the cerebral microcirculation in the pathogenesis of 
stroke in patients with SAHS. These findings are important given that cerebral flow 
adaptation in response to hemodynamic (autoregulation) or metabolic (cerebral vasore-
activity—CVR) changes occur mainly in the microcirculation, and CVR impairment has 
been related to an increased risk of stroke (Silvestrini et al. 2000).
Past studies have found a reduction in the vasodilation response, especially in the bra-
chial artery (Ip et  al. 2004), in patients with SAHS. However, very few have explored 
cerebral hemodynamics and vasoreactivity. In addition, these investigations were usu-
ally performed in small group of patients and gave conflicting results (Placidi et al. 1998; 
Diomedi et al. 1998; Urbano et al. 2008). However, in a recent population-based study, 
Morgan et al. (Morgan et al. 2010) observed a significant positive correlation between 
the mean level of nocturnal oxygen and cerebrovascular CO2 reactivity. Therefore, the 
objective of this study was to further clarify and define the role of cerebral hemodynam-
ics and cerebral vasoreactivity as potential risk factors for stroke in patients with SAHS. 
For these investigations we used a large sample of non-selected SAHS patients and com-




Patients referred to the Sleep Unit for SAHS with an apnea/hypopnea index (AHI) 
≥10/h in overnight full polysomnography were included. Non-SAHS controls were 
selected from the community and hospital staff; subjects with chronic or heavy snoring, 
witnessed nocturnal apneas or excessive daytime sleepiness [Epworth Sleepiness Scale 
(ESS) ≥10] were excluded, although subjects with occasional snoring (less than once a 
week) were accepted. Both groups were matched for age, sex, smoking status, arterial 
hypertension (HT), dyslipidemia, diabetes mellitus (DM), coronary disease (CD) and 
peripheral arteriopathy (PA).
Patients with previous respiratory disease, diurnal hypercapnia (pCO2 > 45 mmHg), 
stroke, arrythmia, cardiac failure or cervical or intracranial arterial stenosis were 
excluded from the study. Diagnosis of HT, dyslipidemia or DM was done by the primary 
physician. The Study Protocol was approved by the Hospital General Universitario Ethic 
Committee. All participants entered the study after giving written informed consent.
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Study measurements
Polysomnography
Sleep study was performed with a SleepLab 1000P (Aequitron Medical Inc, Minneapolis, 
MN, USA) 16-channel polysomnograph. Sleep stages and EEG arousal detection were 
scored according to standard criteria. Apnea was defined as an airflow cessation of more 
than 10  s in both the thermistor and nasal cannula. Hypopnea was defined as a 50  % 
reduction in airflow amplitude of at least 10 s in one airflow signal, with a 4 % oxygen 
desaturation and/or EEG arousal. AHI was defined as the sum of apneas and hypopneas 
per hour during the total sleep time. The oxygen desaturation index (ODI) and arousal 
index (AI) were defined as the respective number of 4 % oxygen desaturations and EEG 
arousals per hour during the total sleep time. CT90 was defined as the percentage of total 
sleep time with O2 saturation under 90  %. All the studies were analyzed by the same 
observer.
Transcranial Doppler study
Baseline study All the subjects were studied in the morning, between 10 a.m. and 12 
a.m., in a quiet, semi-dark room, resting in a supine position. SAHS patients were studied 
within a month of the sleep study. All the tests were performed by the same investiga-
tor, who was blind to the results of the sleep study. First, the participants were routinely 
examined with continuous color-coded duplex ultrasound (Logic Q, GE, linear transducers 
of 5–8 MHz). If a significant (>50 %) stenosis was found, the patient was excluded from 
the study. Second, intracranial arteries (middle cerebral arteries—MCA, anterior cerebral 
arteries—ACA, posterior cerebral arteries—PCA and basilar artery—BA) were identified 
through the temporal (MCA, ACA and PCA) or suboccipital (BA) windows by transcranial 
Doppler (TCD) (Multidop B plus DWL, Elektronische Systeme GmbH, Sipplingen, Ger-
many). The peak systolic velocity (PSV) and end diastolic velocity (EDV) were recorded 
for each artery. The mean blood flow velocity (MFV) was calculated automatically using 
the formula:
A MFV measurement greater than 95th percentile of our normal laboratory values 
in any intracranial artery was indicative of cerebral artery stenosis and the subject was 
excluded from the study.
Breath holding test CVR was assessed by the breath-holding test (BHT). We continu-
ously recorded the right MCA MFV at a depth of 50–55 mm. Participants were asked to 
hold their breaths for 30 s after a normal inspiration. The CBFV increase was recorded as 
the percentage increase in post-apnea MFV compared to the baseline value after breath-
holding (Ratnatunga and Adiseshiah 1990).
Apnea maneuver can induce changes in blood pressure (BP) that could in turn modify 
cerebral hemodynamics. For that, systolic (SBP) and diastolic blood pressure (DBP) were 
measured before and immediately after the breath holding, and BP variations were con-
sidered in data analysis; mean arterial pressure (MAP) was defined as:
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The difference between post-apnea MAP and baseline MAP was defined as:
Statistics
The SPSS 22.0 package (SPSS Inc., Chicago, IL) was used for the analysis. All the data 
were tabulated as mean and standard deviation for quantitative variables and as abso-
lute numbers and percentages in the case of qualitative variables. The Kolmogorov–
Smirnov test was used to analyze variables distribution. When necessary, the variables 
were transformed. In the bivariate analysis, quantitative variables were analyzed using 
the comparison of means tests (Student’s t or Mann–Whitney’s) and χ2 test for categoric 
variables. The linear association between two quantitative variables was established 
using the Pearson linear correlation index or Spearman test. Multivariate analysis was 
performed by multiple linear regression models, including all the independent variables 
that showed an association with dependent variable with p < 0.2. All other independent 
variables relevant for the objectives of the study were also included. The inclusion was 
performed by the “forward” selection method. The strength of the association was meas-




Seventy-eight SAHS patients and seventy-six non-SAHS subjects were referred for TCD 
study. Two SAHS patients were excluded because of significant (>50 %) internal carotid 
artery stenosis and temporal hyperostosis, respectively. The baseline characteristics of 
the participants are shown in Table 1. Although subjects were matched for previous car-
diovascular risk factors, patients with SAHS had significantly higher values of BMI and 
both baseline and post-apnea MAP.
On bivariate analysis, the TCD study showed a significant decrease in MFV (52 ± 9 vs 
60 ± 12 cms/s, p < 0.001) and BHT (31 ± 12 vs 36 ± 11 %, p = 0.005) in SAHS patients 
with respect to non-SAHS (Table 1). MFV was also decreased in participants with previ-
ous coronary disease and showed a negative correlation with BMI. On the other hand, 
BHT was lower in women and in dyslipidemic participants, and also showed a negative 
correlation with age, BMI, and both baseline and post-apnea MAP values (Tables 2, 3).
Multivariate linear regression analysis was performed. The variables included in the 
model explaining MFV were: case/control status, age, gender, BMI, coronary disease and 
baseline MAP. The regression coefficient (R2) was 0.124. MFV correlated negatively with 
the presence of SAHS and coronary disease (Table 4). On the other hand, the variables 
included in the model explaining BHT were: case/control status, age, gender, BMI, dys-
lipidemia, HT, MFV, baseline and post-apnea MAP, and ∆MAP. The regression coeffi-
cient (R2) was 0.115. BHT correlated negatively with the presence of SAHS, female sex 
and baseline MAP (Table 5).
MAP (mmHg) = DBP+
SBP−DBP
3
�MAP (mmHg) = Post-apneaMAP−BaselineMAP
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Table 1 Main characteristics and results of main study
Results are expressed as mean ± standard deviation or number (percentage). Comparison was made by means of Student´s 
t test for continuous variables and χ2 test for categoric variables
SAHS sleep apnea/hypopnea syndrome, M male, F female, BMI body mass index, ESS Epworth Sleepiness Score, HT arterial 
hypertension, DM diabetes mellitus, CD coronary disease, MAP mean arterial pressure, ∆MAP difference between post-apnea 
MAP and baseline MAP, MFV mean flow velocity, BHT breath-holding test
SAHS group Control group p
n 76 76
Gender 67 M/9 F 66 M/10 F 1
Age (years) 48.3 ± 10,5 48.8 ± 11.2 0.8
BMI (kgs/m2) 31.2 ± 4.6 26.9 ± 3.9 <0.001
ESS 12.7 ± 4.1 4.1 ± 1.8 <0.001
HT 21 (27.6 %) 18 (23.6 %) 0.5
Current smoking 26 (34.2 %) 27 (35.5 %) 0.8
Dyslipidemia 25 (32.8 %) 21 (27.6 %) 0.4
DM 2 (2.6 %) 2 (2.6 %) 1
CD 4 (5.3 %) 2 (2.6 %) 0.6
Peripheral arteriopathy 0 0 1
Baseline MAP (mmHg) 106 ± 14 98 ± 12 0.001
Post‑apnea MAP (mmHg) 109 ± 14 101 ± 11 <0.001
∆MAP (mmHg) +3.7 ± 10 +2.7 ± 7 0.4
MFV (cms/sg) 52 ± 9 60 ± 12 <0.001
BHT (%) 31 ± 12 36 ± 11 0.005
Table 2 Comparison of main cardiovascular risk factors by MFV and BHT
Results are expressed as mean ± standard deviation
p value corresponds to means comparison (Student’s t) between each group
HT arterial hypertension, DM diabetes mellitus, CD coronary disease
MFV (cms/sg) BHT (%)
Yes No p Yes No p
Male gender 56 ± 10 58 ± 17 0.560 34 ± 11 28 ± 11 0.025
HT 54 ± 10 57 ± 12 0.213 30 ± 11 34 ± 12 0.057
Current smoking 56 ± 10 56 ± 12 0.814 33 ± 11 33 ± 12 0.963
Dyslipidemia 56 ± 12 56 ± 11 0.996 30 ± 11 35 ± 12 0.017
DM 58 ± 11 56 ± 11 0.633 27 ± 7 34 ± 12 0.300
CD 45 ± 9 56 ± 11 0.022 28 ± 10 34 ± 11 0.285
Table 3 Bivariate analysis (Pearson’s linear correlation)
MFV mean flow value, BHT breath holding test, BMI body mass index, MAP mean arterial pressure, ∆MAP difference between 
post-apnea MAP and baseline MAP
MFV BHT
r p r p
Age −0.097 0.235 −0.162 0.046
BMI −0.230 0.004 −0.199 0.014
Baseline MAP −0.073 0.370 −0.286 <0.001
Post‑apnea MAP −0.234 0.004
∆MAP 0.093 0.254
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SAHS group study
The main polysomnographic values of SAHS patients are shown in Table 6. Overall, and 
although there was no previous selection, this is a group of severe patients with signifi-
cant impact on nocturnal oximetry.
On bivariate analysis (Table  7), MFV correlated negatively with age, ODI and CT90, 
and positively with mean nocturnal O2 saturation. BHT correlated negatively with base-
line MAP. On the other hand, we found no significative correlation between BHT and 
main respiratory variables on polysomnography.
Discussion
The vascular risk factors predisposing to stroke in SAHS are not completely defined. 
In this study, we found that daytime cerebral hemodynamics is abnormal in patients 
affected by SAHS. Specifically, we observed a significant reduction in MFV and BHT in 
the SAHS group when compared to controls. These findings are consistent with changes 
in cerebral circulation, and could indicate a potential greater vulnerability of the cerebral 
vasculature to stroke injury (Silvestrini et al. 2000).
Table 4 Multivariate analysis (multiple linear regression) of MFV
MFV mean flow value, SAHS sleep apnea-hypopnea syndrome, CD coronary disease
MFV Beta Confidence interval p
Low High
SAHS group −7.4 −10.9 −3.8 <0.001
CD −10.3 −19.4 −1.2 0.026
Table 5 Multivariate analysis (multiple linear regression) of BHT
BHT breath-holding test, SAHS sleep apnea-hypopnea syndrome, MAP mean arterial pressure
BHT Beta Confidence interval p
Low High
SAHS group −4.04 −7.7 −0.3 0.034
Female gender −5.9 −11.3 −0.44 0.034
Baseline MAP −0.190 −0.32 −0.05 0.005
Table 6 Polysomnographic values in SAHS group
SAHS sleep apnea/hypopnea syndrome, AHI apnea/hypopnea index, ODI 4 % oxygen desaturation index, AI EEG arousal 
index, CT90 total sleep time percentage with O2 saturation lower than 90 %
Mean SD Range
AHI (number/h) 58.9 24.3 10–122
ODI (number/h) 40.0 28.4 0–92
AI (number/h) 58.4 21.1 19–121
Baseline O2 saturation (%) 96.1 1.2 92–98
Mean O2 saturation (%) 91.7 2.7 81–96
Minimal O2 saturation (%) 74.8 10.1 42–90
CT90 (%) 22.2 28.0 0–97
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Reduced MFV in SAHS has been scarcely reported in previous studies and little 
importance has been given to this finding in most of them (Urbano et al. 2008; Fisher 
et al. 1992). Lower MFV has been related to cognitive impairment and to the severity of 
nocturnal hypoxia in SAHS (Findley et al. 1986). However, the cause of this impairment 
in cerebral blood flow is not known. Cerebral flow velocity may be reduced relative to an 
increase in peripheral resistance associated with small vessel disease, as it has been sug-
gested in some studies (Minoguchi et al. 2007). On the other hand, we cannot exclude 
that low MFV could also be produced as a consequence of changes in the cross-sectional 
area of the middle cerebral artery. Carotid artery dilation, which is present in early stages 
of atherosclerosis, has been found in SAHS patients free of cardiovascular comorbidi-
ties (Drager et al. 2007). Moreover, a recent magnetic resonance imaging study (Cover-
dale et al. 2014) demonstrates a significant increase in middle cerebral artery diameter 
following acute hypercapnic challenge in healthy subjects; therefore, it is possible that 
continuous heavy exposure to nocturnal hypercapnia as occurs in severe SAHS patients 
could have induced and perhaps maintained such vascular changes. Response to treat-
ment could have helped us to identify pathophysiologic mechanisms leading to this cer-
ebral blood flow impairment. However, there are few available studies. Diomedi et  al. 
(Diomedi et al. 1998) did not report significant changes in MFV after a month of con-
tinuous positive airway pressure (CPAP) treatment. We followed part of the present 
cohort after a mean period of two years of CPAP treatment and what we found was a 
small, but significant further impairment of MFV (Jiménez-Caballero et  al. 2013). In 
summary, impaired MFV in this cohort of severe SAHS patients could be related to 
vascular changes, probably involving small vessels and perhaps large intracranial arter-
ies too. According to the few available studies, CPAP treatment did not seem to modify 
this hemodynamic impairment and this could have prognostic implications since SAHS 
mainly affects middle-aged adults who may be at increased risk for the rest of their lives. 
Further studies will be needed to better define the importance of this finding as a cardio-
vascular risk factor.
Table 7 Bivariate analysis (Pearson´s linear correlation) in SAHS group study
MFV mean flow velocity, BHT breath-holding test, AHI apnea/hypopnea index, ODI 4 % oxygen desaturation index, AI EEG 
arousal index, CT90 total sleep time percentage with O2 saturation lower than 90 %, MAP mean arterial pressure, ∆MAP 
difference between post-apnea MAP and baseline MAP
MFV BHT
r p r p
AHI (number/h) −0.162 0.162 −0.139 0.232
ODI (number/h) −0.271 0.018 0.112 0.340
AI (number/h) −0.085 0.468 −0.096 0.407
Baseline O2 saturation (%) 0.198 0.086 0.053 0.649
Mean O2 saturation (%) 0.232 0.043 0.048 0.682
Minimal O2 saturation (%) 0.169 0.144 −0.128 0.269
CT90 (%) −0.307 0.007 0.061 0.599
Baseline MAP (mmHg) 0.195 0.095 −0.346 0.002
Post‑apnea MAP (mmHg) −0.189 0.103
∆MAP (mmHg) 0.218 0.059
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We also found CVR impairment in SAHS patients as described in previous studies, 
most of them including a small number of severe patients. Placidi et  al. (Placidi et  al. 
1998), also using BHT, found a reduction of CVR in a group of patients with severe 
SAHS when compared to controls. In contrast, four subsequent studies (Urbano et al. 
2008; Foster et  al. 2009; Furtner et  al. 2009; Ryan et  al. 2014) did not. However, in a 
recent population-based study, Morgan et al. (Morgan et al. 2010) describe CVR impair-
ment across a wide spectrum of sleep-breathing disorders in a large sample of 373 par-
ticipants of the Sleep Heart Health Study cohort; they observed a positive correlation 
between mean level of arterial oxygen during sleep and vascular cerebral responsiveness 
to hypercapnia. Many pathophysiological mechanisms can be involved. Endothelial dys-
function and improvement with CPAP have been described in peripheral circulation in 
SAHS patients (Ip et al. 2004). Moreover, early markers of carotid atherosclerosis have 
been found and a positive response to treatment has been reported (Drager et al. 2007); 
therefore, endothelial dysfunction described in peripheral and extracranial arteries 
could also involve intracranial arteries. On the other hand, high sympathetic activity by 
itself could cause CVR impairment, as it has been proved in healthy subjects (ter Laan 
et al. 2013). High nocturnal sympathetic activity is almost always present in severe SAHS 
patients and may remain in the morning, and previous studies show that CPAP treat-
ment can normalize morning levels of catecholamines after a single night of treatment 
(Minemura et al. 1998). Interestingly, Diomedi et al. (Diomedi et al. 1998) also reported 
an early improvement in CVR in patients after a first night with CPAP, and this effect 
was maintained a month later. We also found a significant improvement of CVR in our 
SAHS cohort after two years of follow-up (Jiménez-Caballero et al. 2013), together with 
significantly lower diastolic blood pressure levels. Therefore, although endothelial dys-
function is present in severe SAHS patients and could probably contribute to vasodilata-
tion impairment, the early improvement of CVR with CPAP described in interventional 
studies suggests that high sympathetic activity could also account for a big part of the 
hemodynamic disturbance.
In the present study, we also found that decrease in CVR was independently related to 
high baseline BP values, indicating either unknown or poorly controlled hypertension. 
Chronic hypertension causes endothelial dysfunction and vasodilatation impairment. 
Moreover, one recent well-designed study (Drager et  al. 2009) has found a significant 
increase in early markers of carotid atherosclerosis in hypertensive SAHS patients com-
pared to healthy controls, non-hypertensive SAHS or hypertensive non-SAHS subjects 
respectively, suggesting that SAHS and hypertension could have an accumulative effect 
in vascular damage in these patients.
Another important finding from our study is the association of impaired CVR with 
female sex. Even though female sex is not a risk factor per se, greater reduction in CVR 
has been found in post-menopausal women as compared to premenopausal women and 
men of all ages (Matteis et al. 1998). Moreover, impaired endothelial function associated 
with sleep-breathing disorders has also been described in women, but not in men, in a 
cohort study of 193 participants (Faulx et al. 2004). In our study, women were signifi-
cantly older than men (mean age 54 ± 8 vs 47 ± 10 years, p = 0.006, data not shown) and 
most of them would probably be menopausal, although these data were not recorded in 
our questionnaire.
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In our SAHS group, MFV reduction was related to oxygen desaturation severity, but 
not to AHI. Oxygen desaturation severity has also been correlated with the presence of 
early markers of carotid atherosclerosis (Baguet et al. 2005) and of silent brain infarc-
tion (Minoguchi et al. 2007) in SAHS patients. In the study by Morgan et al. (Morgan 
et  al. 2010), nocturnal oxygen saturation was also a more important predictor of cer-
ebral vascular dysfunction than was AHI. We did not find any correlation between BHT 
and respiratory variables in our SAHS patients; as most of them had severe disease, we 
believe that this could explain the absence of significant correlation with hemodynamic 
impairment; in this sense, it would be interesting to perform this study in a sample of 
less severe SAHS patients.
Our study has some potential limitations. First of all, a limitation in the TCD method-
ology is the correlation of the CBFV with cerebral flow when the MCA diameter remains 
constant at the point of insonation. Although previous studies did not find any signifi-
cant difference in the diameter of the artery during changes in end-tidal CO2, a more 
recent paper (Coverdale et  al. 2014) describes a significant increase in cross-sectional 
area of MCA during hypercapnia in healthy volunteers. Second, we did not perform 
a sleep study in the non-SAHS group; therefore, we cannot rule out an AHI  >  5/h in 
some cases. However, since none of these subjects reported habitual snoring, witnessed 
apneas or excessive daytime somnolence, this possibility is less likely. This is supported 
by previous studies demonstrating that only 6 % of SAHS patients are not snorers (Viner 
et al. 1991). Third, and despite a random selection process, the mean baseline and post-
apnea BP values were significantly higher in the SAHS group, suggesting the possibil-
ity of undiagnosed HT in some cases. Chronic HT could have explained the low values 
in MFV and BHT. However, the differences between groups remained significant after 
adjusting for these confounding factors.
In summary, our study highlights the impairment of daytime cerebral hemodynamics 
in patients with severe SAHS. These findings point out to possible functional and struc-
tural changes in cerebral microcirculation and perhaps in large intracranial arteries too 
as a potential mechanism to help to explain the increased risk of stroke in these patients. 
Further studies will be needed to identify risk groups more accurately and to evaluate 
possible changes in cerebral hemodynamics after therapeutic intervention.
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